News
Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...
Pfizer saw a staggering increase in call options trading, with investors snapping up 539,824 contracts, marking a 286% jump ...
18h
Zacks Investment Research on MSNPfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on ItPfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
21h
InvestorsHub on MSNPfizer and BioNTech Receive Positive EMA Backing for Updated COVID VaccinePfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...
Fiserv stock sank Wednesday after the fintech posted results for the fiscal second quarter. While earnings and revenue topped ...
The completion of this study may positively influence Pfizer’s stock performance by demonstrating the effectiveness and safety of INLYTA® in real-world settings, potentially boosting investor ...
Study Design: This interventional study is randomized and follows a parallel assignment model. It is double-blind, meaning neither participants nor the care providers, investigators, or outcome ...
Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...
Pfizer stock opened with a sharp spike before slipping below its previous close, showing signs of morning volatility and resistance. The stock briefly hit an intraday high of $25.53 but quickly fell ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Value stocks are generally companies that trade at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results